Developer docs
API playgroundTry for free, no card

Search company profiles

SJJ Solutions

Full company profile

uuid00382do

Namestring
SJJ Solutions
Legal namestring
SJJ Solutions B.V.
Company typeenum
Private
Founded yearint
2012
Descriptiontext

SJJ Solutions B.V. is a Dutch medical device company headquartered in The Hague, Netherlands, founded in 2012, that designs, manufactures, and sells the Zero Residual™ product line — an integrated system of silicone oil-free syringes, needles, bubble adapters, luer lock caps, and silicone oil-free filter needles for small-volume drug delivery. The flagship Zero Residual™ 0.2ml silicone oil-free syringe, which received CE MDR approval in December 2022 as the world's first such device specifically tailored for intravitreal injections, targets ophthalmologists and compounding pharmacies performing anti-VEGF injections for wet-AMD, diabetic macular edema, and retinal vein occlusion; the company also identifies mRNA-based vaccines and gene & cell therapy as secondary application segments. The technology is differentiated by peer-reviewed performance data showing +0.70% dosing accuracy (vs. +9.42-19.41% for standard syringes), residual volume of ~1.4μL (vs. 24.86-51.97μL), and dramatically lower silicone oil particle release after agitation.

The company operates a direct enterprise field sales model targeting healthcare facilities and compounding pharmacies, supported by eight regional vice presidents covering North America, Western Europe, Northern Europe, DACH, LATAM, APAC Southeast Asia, Middle East & Africa, and Central Eastern Europe / ANZ / South Asia, plus a dedicated US website. Revenue is generated exclusively through hardware sales of proprietary CE-marked devices; pricing is not publicly disclosed and quotes are issued on request. SJJ Solutions is a privately held, family-controlled B.V. (Dutch Chamber of Commerce registration 71377352), with multiple Schootstra family members holding CEO, CIO, and Principal Engineer roles; the only disclosed external capital is a 2023 Kansen voor West III EU subsidy funding R&D for the ZR-concept 2.0 next-generation platform. Key commercial relationships include an industry development agreement with Inven2 (the commercialization arm of Oslo University Hospital and the South-Eastern Norway Regional Health Authority) and a 2021 collaboration with the Dutch RIVM during the COVID-19 vaccination campaign.

Short descriptiontext

SJJ Solutions is a Dutch medical device company that designs and sells the Zero Residual™ integrated silicone oil-free syringe system for precision small-volume drug delivery, primarily serving ophthalmologists and compounding pharmacies performing intravitreal anti-VEGF injections.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersThe Hague, Netherlands
HQ citystring
The Hague
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ophthalmic medical devices, intravitreal injection syringes, silicone oil-free syringes, small volume drug delivery, medical device manufacturing
Industry2 codes
PRIMARYHLAHAIAL
Ocular Drug Delivery Devices (Eye Droppers/Inserts)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLAHAIAA
Prefilled Syringes & Safety Syringes
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
NAICS code3 codes
  • Ophthalmic Goods Manufacturing339115
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Ophthalmic Goods3851
Product category
Ophthalmic Medical Devices
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

SJJ Solutions generates revenue through the sale of proprietary medical devices including syringes, needles, bubble adapters, filter needles, and caps. Products are sold directly to healthcare facilities, compounding pharmacies, and ophthalmology practices. The company serves multiple markets including ophthalmic, mRNA-based vaccines, and gene & cell therapy.

sjjsolutions.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Zero Residual™
Description

The company's core product concept and brand for silicone oil-free syringes and related medical devices designed for small volume dosing in ophthalmic and other medical applications.

sjjsolutions.com
Core offering1 text field

SJJ Solutions designs, develops, manufactures, and sells the Zero Residual™ product line — silicone oil-free syringes, needles, bubble adapters, Luer Lock caps, and silicone oil-free filter needles — for small volume drug delivery in ophthalmic (intravitreal) injections. Products are CE MDR-approved and ISO 9001 certified, sold directly to healthcare facilities, eye clinics, compounding pharmacies, and ophthalmic specialists worldwide.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Zero Residual Silicone Oil-free syringe shows +0.70% dosing accuracy compared to standard syringes ranging from +9.42% to +19.41% deviation
+4 more records
Product overview1 text field

SJJ Solutions offers the Zero Residual™ product line—a modular system of medical devices for small volume dosing in ophthalmic applications. The core offering centers on the Zero Residual™ 0.2ml silicone oil-free syringe, complemented by specialized needles (30G, 33G in various lengths), the Bubble Adapter for air-free prefilling, Luer Lock cap, and silicone oil-free filter needle. An additional 0.3ml low silicone syringe variant extends the portfolio. All components are designed for interoperability, targeting anti-VEGF injections for wet-AMD and DME treatments, as well as mRNA-based vaccines and gene & cell therapy applications.

Product and service6 records
1Zero Residual™ 0.2ml SiO-free Syringe
CategoryOphthalmic Medical Devices - Syringes
Description

The first CE-approved silicone oil-free syringe designed for small volume dosing, specifically tailored for intravitreal injections. Features a 0.2mL capacity with Luer Lock connection, 2.48mm inner diameter, and 11mm stroke length for precise dosing control.

2Zero Residual™ Needles
CategoryOphthalmic Medical Devices - Needles
Description

Injection needles designed to fit exactly on all Zero Residual™ syringes, available in 30G and 33G gauges with 9mm and 13mm lengths. Each batch is tested for sharpness before release.

3Zero Residual™ Bubble Adapter
CategoryOphthalmic Medical Devices - Accessories
Description

CE MDR approved adapter that enables air-free prefilling of syringes. Solves the common problem of filling syringes with filter needles while preventing air bubble introduction and reducing silicone oil contamination risk.

4Zero Residual™ Cap
CategoryOphthalmic Medical Devices - Accessories
Description

Luer Lock cap allowing air-free prefilling of Zero Residual™ syringes. The design ensures firm seal and closure integrity of prefilled syringes.

5Zero Residual™ SiO-free Filter Needle
CategoryOphthalmic Medical Devices - Filter Needles
Description

The world's first commercially available silicone oil-free filter needle. Eliminates potential silicone oil risk when using filter needles with Zero Residual™ products, completing the silicone oil-free path from vial to patient.

6Zero Residual™ 0.3ml Low Silicone Syringes
CategoryOphthalmic Medical Devices - Syringes
Description

Low silicone content syringes with 0.3ml capacity designed for small volume injections, complementing the zero residual product line.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Oslo University Hospital is a highly specialized hospital with regional and local responsibilities and national missions across multiple competency centers. The hospital collaborated with SJJ Solutions on research and development of the Zero Residual syringe concept, contributing clinical expertise and validation capabilities. Collaborative agreements exist related to the development of syringes by SJJ Solutions.

2Inven2
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Inven2 is responsible for evaluating and commercializing innovative research from the University of Oslo, Oslo University Hospital, and health trusts under the South-Eastern Norway Regional Health Authority. SJJ Solutions signed an industry development agreement with Inven2 for collaborative product development and commercialization.

sjjsolutions.com
Recent move12 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

German medical device and pharmaceutical company with an extensive syringe and infusion therapy portfolio. Its Integra and Omnifix syringe lines are used across European hospital pharmacies and could be repositioned with low-residual designs.

TypeRegional player
Description

European pharmaceutical packaging and specialty glass manufacturer producing primary packaging for injectables including syringes. Adjacent to SJJ's category with deep European manufacturing footprint and biopharma customer relationships.

TypeDirect peer
Description

Manufacturer of precision syringes including specialty low-volume models used in analytical and medical applications. Hamilton's glass syringes are widely used in ophthalmic compounding, making it one of the most direct product competitors to SJJ's Zero Residual™ system.

4Nipro Corporation
TypeDirect peer
Description

Japanese medical device manufacturer with a comprehensive syringe and needle product line distributed globally. Nipro's specialty syringes serve ophthalmology and diabetes markets, positioning it as a direct functional peer.

5Smiths Medical (ICU Medical)
TypeBroad incumbent
Description

Specialty medical device company with syringe pumps, injection devices, and safety needles serving hospital and ophthalmology markets. Comparable in scale to a potential acquirer and a meaningful channel for ophthalmic injection products.

TypeEmerging player
Description

Italian drug containment and delivery solutions provider serving biologics manufacturers with syringes, vials, and devices. Comparable in their focus on high-value injectable packaging and their growing presence in the ophthalmic biologics supply chain.

TypeBroad incumbent
Description

Global medical technology leader with a large syringe and drug delivery portfolio including 1ml low-dead-volume syringes used by compounding pharmacies for intravitreal injections. BD is the dominant incumbent whose products SJJ displaces in ophthalmology workflows.

8Terumo Corporation
TypeBroad incumbent
Description

Japanese medical device manufacturer with a substantial syringe and injection device business serving hospitals globally. Terumo has the R&D scale and global distribution to enter the silicone oil-free ophthalmic syringe segment if market demand is proven.

TypeBroad incumbent
Description

Leader in elastomer components, syringe plungers, and drug containment/delivery systems serving injectable biologics. West works closely with anti-VEGF manufacturers on packaging and could integrate silicone oil-free components into its offering.

TypeEmerging player
Description

UK-based specialty medical device manufacturer of injection and blood sampling devices. Comparable in being a mid-sized specialty device company with proprietary delivery technology and direct healthcare provider relationships.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SJJ Solutions

Ophthalmic Medical Devicessjjsolutions.com

SJJ Solutions is a Dutch medical device company that designs and sells the Zero Residual™ integrated silicone oil-free syringe system for precision small-volume drug delivery, primarily serving ophthalmologists and compounding pharmacies performing intravitreal anti-VEGF injections.

What SJJ Solutions does

SJJ Solutions B.V. is a Dutch medical device company headquartered in The Hague, Netherlands, founded in 2012, that designs, manufactures, and sells the Zero Residual™ product line — an integrated system of silicone oil-free syringes, needles, bubble adapters, luer lock caps, and silicone oil-free filter needles for small-volume drug delivery. The flagship Zero Residual™ 0.2ml silicone oil-free syringe, which received CE MDR approval in December 2022 as the world's first such device specifically tailored for intravitreal injections, targets ophthalmologists and compounding pharmacies performing anti-VEGF injections for wet-AMD, diabetic macular edema, and retinal vein occlusion; the company also identifies mRNA-based vaccines and gene & cell therapy as secondary application segments. The technology is differentiated by peer-reviewed performance data showing +0.70% dosing accuracy (vs. +9.42-19.41% for standard syringes), residual volume of ~1.4μL (vs. 24.86-51.97μL), and dramatically lower silicone oil particle release after agitation.

The company operates a direct enterprise field sales model targeting healthcare facilities and compounding pharmacies, supported by eight regional vice presidents covering North America, Western Europe, Northern Europe, DACH, LATAM, APAC Southeast Asia, Middle East & Africa, and Central Eastern Europe / ANZ / South Asia, plus a dedicated US website. Revenue is generated exclusively through hardware sales of proprietary CE-marked devices; pricing is not publicly disclosed and quotes are issued on request. SJJ Solutions is a privately held, family-controlled B.V. (Dutch Chamber of Commerce registration 71377352), with multiple Schootstra family members holding CEO, CIO, and Principal Engineer roles; the only disclosed external capital is a 2023 Kansen voor West III EU subsidy funding R&D for the ZR-concept 2.0 next-generation platform. Key commercial relationships include an industry development agreement with Inven2 (the commercialization arm of Oslo University Hospital and the South-Eastern Norway Regional Health Authority) and a 2021 collaboration with the Dutch RIVM during the COVID-19 vaccination campaign.

SJJ Solutions firmographics

Firmographics
Name
SJJ Solutions
Legal name
SJJ Solutions B.V.
Website
https://sjjsolutions.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
51–100 employees
Short description
SJJ Solutions is a Dutch medical device company that designs and sells the Zero Residual™ integrated silicone oil-free syringe system for precision small-volume drug delivery, primarily serving ophthalmologists and compounding pharmacies performing intravitreal anti-VEGF injections.
Ownership category
akta.pro rank

SJJ Solutions industry classification

Industry
Product category
Ophthalmic Medical Devices
NAICS
Ophthalmic Goods Manufacturing (339115), Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), Ophthalmic Goods (3851)
akta.pro industry
PRIMARYHLAHAIAL
Ocular Drug Delivery Devices (Eye Droppers/Inserts)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLAHAIAA
Prefilled Syringes & Safety Syringes
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)

Keywords

  • Ophthalmic medical devices
  • Intravitreal injection syringes
  • Silicone oil-free syringes
  • Small volume drug delivery
  • Medical device manufacturing

Where SJJ Solutions is headquartered

Location

Headquarters

HQ city
The Hague
HQ country
Netherlands
HQ region
Europe

Offices2 records

Markets served

SJJ Solutions business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Sales: SJJ Solutions generates revenue through the sale of proprietary medical devices including syringes, needles, bubble adapters, filter needles, and caps. Products are sold directly to healthcare facilities, compounding pharmacies, and ophthalmology practices. The company serves multiple markets including ophthalmic, mRNA-based vaccines, and gene & cell therapy.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

SJJ Solutions product offering

Product offering

Core offering

SJJ Solutions designs, develops, manufactures, and sells the Zero Residual™ product line — silicone oil-free syringes, needles, bubble adapters, Luer Lock caps, and silicone oil-free filter needles — for small volume drug delivery in ophthalmic (intravitreal) injections. Products are CE MDR-approved and ISO 9001 certified, sold directly to healthcare facilities, eye clinics, compounding pharmacies, and ophthalmic specialists worldwide.

Product overview

SJJ Solutions offers the Zero Residual™ product line—a modular system of medical devices for small volume dosing in ophthalmic applications. The core offering centers on the Zero Residual™ 0.2ml silicone oil-free syringe, complemented by specialized needles (30G, 33G in various lengths), the Bubble Adapter for air-free prefilling, Luer Lock cap, and silicone oil-free filter needle. An additional 0.3ml low silicone syringe variant extends the portfolio. All components are designed for interoperability, targeting anti-VEGF injections for wet-AMD and DME treatments, as well as mRNA-based vaccines and gene & cell therapy applications.

Differentiator

Problem solved

Functional benefit

Brands

  • Zero Residual™: The company's core product concept and brand for silicone oil-free syringes and related medical devices designed for small volume dosing in ophthalmic and other medical applications.

Products and services

  • Zero Residual™ 0.2ml SiO-free Syringe The first CE-approved silicone oil-free syringe designed for small volume dosing, specifically tailored for intravitreal injections. Features a 0.2mL capacity with Luer Lock connection, 2.48mm inner diameter, and 11mm stroke length for precise dosing control.
  • Zero Residual™ Needles Injection needles designed to fit exactly on all Zero Residual™ syringes, available in 30G and 33G gauges with 9mm and 13mm lengths. Each batch is tested for sharpness before release.
  • Zero Residual™ Bubble Adapter CE MDR approved adapter that enables air-free prefilling of syringes. Solves the common problem of filling syringes with filter needles while preventing air bubble introduction and reducing silicone oil contamination risk.
  • Zero Residual™ Cap Luer Lock cap allowing air-free prefilling of Zero Residual™ syringes. The design ensures firm seal and closure integrity of prefilled syringes.
  • Zero Residual™ SiO-free Filter Needle The world's first commercially available silicone oil-free filter needle. Eliminates potential silicone oil risk when using filter needles with Zero Residual™ products, completing the silicone oil-free path from vial to patient.
  • Zero Residual™ 0.3ml Low Silicone Syringes Low silicone content syringes with 0.3ml capacity designed for small volume injections, complementing the zero residual product line.

Quantifiable outcome

  • Zero Residual Silicone Oil-free syringe shows +0.70% dosing accuracy compared to standard syringes ranging from +9.42% to +19.41% deviation
  • +4 more outcomes

Companies that use SJJ Solutions

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

SJJ Solutions technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

SJJ Solutions partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Oslo University HospitalcoreStrategic or Co-development PartnerOslo University Hospital is a highly specialized hospital with regional and local responsibilities and national missions across multiple competency centers. The hospital collaborated with SJJ Solutions on research and development of the Zero Residual syringe concept, contributing clinical expertise and validation capabilities. Collaborative agreements exist related to the development of syringes by SJJ Solutions.
  • Inven2coreStrategic or Co-development PartnerInven2 is responsible for evaluating and commercializing innovative research from the University of Oslo, Oslo University Hospital, and health trusts under the South-Eastern Norway Regional Health Authority. SJJ Solutions signed an industry development agreement with Inven2 for collaborative product development and commercialization.

Scale indicators3 records

Recent moves12 records

Expansion highlights6 records

SJJ Solutions competitors and assessment

Company assessment

Broad incumbents

  • B. Braun Melsungen: German medical device and pharmaceutical company with an extensive syringe and infusion therapy portfolio. Its Integra and Omnifix syringe lines are used across European hospital pharmacies and could be repositioned with low-residual designs.
  • Smiths Medical (ICU Medical): Specialty medical device company with syringe pumps, injection devices, and safety needles serving hospital and ophthalmology markets. Comparable in scale to a potential acquirer and a meaningful channel for ophthalmic injection products.
  • Becton, Dickinson and Company (BD): Global medical technology leader with a large syringe and drug delivery portfolio including 1ml low-dead-volume syringes used by compounding pharmacies for intravitreal injections. BD is the dominant incumbent whose products SJJ displaces in ophthalmology workflows.
  • Terumo Corporation: Japanese medical device manufacturer with a substantial syringe and injection device business serving hospitals globally. Terumo has the R&D scale and global distribution to enter the silicone oil-free ophthalmic syringe segment if market demand is proven.
  • West Pharmaceutical Services: Leader in elastomer components, syringe plungers, and drug containment/delivery systems serving injectable biologics. West works closely with anti-VEGF manufacturers on packaging and could integrate silicone oil-free components into its offering.

Regional players

  • Gerresheimer AG: European pharmaceutical packaging and specialty glass manufacturer producing primary packaging for injectables including syringes. Adjacent to SJJ's category with deep European manufacturing footprint and biopharma customer relationships.

Direct peers

  • Hamilton Company: Manufacturer of precision syringes including specialty low-volume models used in analytical and medical applications. Hamilton's glass syringes are widely used in ophthalmic compounding, making it one of the most direct product competitors to SJJ's Zero Residual™ system.
  • Nipro Corporation: Japanese medical device manufacturer with a comprehensive syringe and needle product line distributed globally. Nipro's specialty syringes serve ophthalmology and diabetes markets, positioning it as a direct functional peer.

Emerging players

  • Stevanato Group: Italian drug containment and delivery solutions provider serving biologics manufacturers with syringes, vials, and devices. Comparable in their focus on high-value injectable packaging and their growing presence in the ophthalmic biologics supply chain.
  • Owen Mumford: UK-based specialty medical device manufacturer of injection and blood sampling devices. Comparable in being a mid-sized specialty device company with proprietary delivery technology and direct healthcare provider relationships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks4 records

Key highlights7 records

Customer concentration

SJJ Solutions social profiles

Digital presence

SJJ Solutions compliance and trust

Trust signal

Compliance3 records

SJJ Solutions financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SJJ Solutions leadership team

Management profile

Number of profiles

Profiles14 records

SJJ Solutions funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SJJ Solutions M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SJJ Solutions

What does SJJ Solutions do?

SJJ Solutions designs, develops, manufactures, and sells the Zero Residual™ product line — silicone oil-free syringes, needles, bubble adapters, Luer Lock caps, and silicone oil-free filter needles — for small volume drug delivery in ophthalmic (intravitreal) injections. Products are CE MDR-approved and ISO 9001 certified, sold directly to healthcare facilities, eye clinics, compounding pharmacies, and ophthalmic specialists worldwide.

Is SJJ Solutions a public or private company?

SJJ Solutions is a private company. It is classified as family owned and is currently operating.

When was SJJ Solutions founded?

SJJ Solutions was founded in 2012. It employs 51 to 100 people.

Where is SJJ Solutions based?

SJJ Solutions is headquartered in The Hague, Netherlands, in the Europe region.

How does SJJ Solutions make money?

One revenue line is on record: medical Device Sales.

Who are SJJ Solutions's main competitors?

Broad incumbents on record are B. Braun Melsungen, Smiths Medical (ICU Medical), Becton, Dickinson and Company (BD), Terumo Corporation and West Pharmaceutical Services. Gerresheimer AG is listed as a regional player. Direct peers are Hamilton Company and Nipro Corporation. Emerging players are Stevanato Group and Owen Mumford.

Does SJJ Solutions have an API?

No public API is recorded for SJJ Solutions.

What industry is SJJ Solutions in?

SJJ Solutions's product category is Ophthalmic Medical Devices. Its primary akta.pro industry code is HLAHAIAL, Ocular Drug Delivery Devices (Eye Droppers/Inserts), with a secondary code of HLAHAIAA, Prefilled Syringes & Safety Syringes. Its NAICS code is 339115 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales